Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in Top Stories

Quan Capital Closes Second Healthcare Fund at $275 Million
HiFiBiO Closes $67 Million C Round for Immune Modulators
Biotheus Signs $142 Million Deal for Alligator Bio TNFR Antibody
Nanjing Frontier Biotech Plans $285 Million IPO on Shanghai STAR Exchange
Chipscreen Bio Climbs 367% on First Trading Day following Shanghai IPO
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital